National and Kapodistrian University of Athens
Η διαγνωστική αξία των υπερήχων στις φλεγμονώδεις παθήσεις του εντέρου
Abstract
dc:descriptionObjective: Improvements in technology of transabdominal ultrasound, and increas-ing experience with sonographic findings in a variety of intestinal diseases including inflammatory bowel disease , have contributed to firmly establishing the role of ultra-sound as a clinically important, non-invasive and widely available imaging modality. The aim of the present study is to determine the current role of bowel US in the diag-nostic work-up of patients with IBD. We furthermore, studied the correlation between the active phase of the diseases and the angiogenetic factors VEGF and bFGF in the patient’s blood serum.Material and Methods: We enrolled 40 patients of the Department of Gastroenterol-ogy that were admitted to the hospital either for relapsing of an already diagnosed in-flammatory bowel disease, or because of a recent diagnosed disease. All patients followed the clinic’s diagnostic protocol and after that, they were evaluated with transabdominal ultrasound, by the same examiner. At the same time we measured the angiogenetic factors VGEF and bFGF, using ELISA, at blood samples taken from the patients and from a group of 40 healthy witnesses.Results: The diagnosis of the inflammatory bowel diseases was performed in our study with a sensitivity of 94, 9%. The highest sensitivity values were achieved in the sigmoid colon, while a diseased rectum was difficult to detect and sensitivity values dropped at 43,5%. Crohn’s disease was detected with a sensitivity of 90,5% and the positive prognostic value was 100%. Surprisingly, ultrasound’s sensitivity for the de-tection of ulcerative colitis was 100% but still rectum was the most difficult anatomic area to explore. VEGF was found to be significantly elevated in our patients group, but this was not verified for bFGF.Conclusion: During recent years high resolution bowel ultrasound has proved to be an accurate non-invasive procedure for the detection of the inflammatory bowel dis-eases. It may be used as a screening imaging technique in patients with clinically suspected disease where it is sufficiently accurate and well accepted by patients. It can also be used in patients with relapsing disease and it can address the most ap-propriate following diagnostic procedure to be chosen according to the anatomical site of the diseased bowel walls depicted at ultrasound. VEGF factor seems to be strictly related with the active phase of the disease but this has not been verified for bFGF factor.
Degree
thesis:*- Grantor dc:publisher
- National and Kapodistrian University of Athens
- Year dc:date
- 2012
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Kopanakis, Nikolaos
- Κοπανάκης, Νικόλαος
Subjects
dc:subject × 15Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/29611